Search for: "Wall v. Wall et al" Results 581 - 600 of 670
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Oct 2010, 10:25 pm by IP Dragon
See David Michael et al, Beyond the Great Wall, Intellectual Property Strategies for Chinese Companies, Boston Consulting Group, January 2007. [read post]
5 Oct 2011, 12:41 pm by Lyle Denniston
Equal Employment Opportunity Commission, et al. [read post]
12 Oct 2017, 4:22 pm by INFORRM
Earlier I posted about the European Commission’s Communication on Illegal Content Online. [read post]
24 Oct 2023, 9:01 pm by renholding
I’d like to start by returning to a theme that I’ve touched on before, and that is how public trust in our institutions is faltering.[1] No sector is immune from this trend. [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge),  (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
1 May 2016, 1:49 pm by streetartandlaw
§ 1125(a)) Relief for Unfair Competition Under California Business And Professions Code §§ 17200 et seq. [read post]
1 Sep 2010, 11:46 am by Roshonda Scipio
[et al.].Cambridge ; New York : Cambridge University Press, 2010.International Criminal LawKZ6304.5.E94 C66 2010Fact-finding without facts : the uncertain evidentiary foundations of international criminal convictions / Nancy Amoury Combs.Combs, Nancy A., 1965-Cambridge ; New York : Cambridge University [read post]
2 Nov 2009, 8:05 am
The fine line between hedging and speculation    For those not familiar with the derivatives market, the word “derivatives” is synonymous with corporate scandals, Wall Street opulence, or highly risky investments that often lead to bankruptcy. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
13 Jul 2021, 10:58 am by Simon Lester
This is a guest post from law professor Michael Trebilcock and lawyer Dan Poliwoda:     THE TRIPS VACCINE WAIVER CONTROVERSY* By Michael Trebilcock Emeritus University Professor of LawUniversity of Toronto     Dan Poliwoda Lawyer, Dickinson Wright LLP University of Toronto (J.D., 2020)    July 12, 2021 *We acknowledge the invaluable research assistance of Daniel Scarpitti, University of Toronto, Faculty of Law, 2L, in preparing these comments. [read post]